Literature DB >> 21971000

Structural properties of human monoamine oxidases A and B.

Claudia Binda1, Andrea Mattevi, Dale E Edmondson.   

Abstract

The structural elucidations of human monoamine oxidases A and B (MAO-A and -B) have provided novel insights into their similarities and differences. Although the enzymes exhibit ∼70% sequence identities, highly conserved chain folds, and are structurally identical in their flavin adenine dinucleotide (FAD)-binding sites, they differ considerably in the structures of their active sites opposite the flavin cofactor. MAO-A has a monopartite cavity of ∼550 ų, and MAO-B exhibits a bipartite cavity structure with an entrance cavity of 290 ų and a substrate cavity of ∼400 ų. Ile199 functions as a conformational "gate" separating the two cavities. Both enzymes are anchored to the outer mitochondrial membrane via C-terminal helical tails. Loop structures are found at the entrances to their active sites at the membrane surface. Although the crystal structure of human MAO-A is monomeric while MAO-B is dimeric, both enzymes are dimeric in their membrane-bound forms. Dimerization may be important for the favorable orientation of the resultant protein dipole moment toward the anionic membrane surface.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971000     DOI: 10.1016/B978-0-12-386467-3.00001-7

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  16 in total

1.  4-Organoseleno-Isoquinolines Selectively and Reversibly Inhibit the Cerebral Monoamine Oxidase B Activity.

Authors:  Tuane Bazanella Sampaio; Juliana Trevisan Da Rocha; Marina Prigol; Rogério Aquino Saraiva; Pablo Froner Nogara; André Luiz Agnes Stein; João Batista Teixeira da Rocha; Gilson Zeni; Cristina Wayne Nogueira
Journal:  J Mol Neurosci       Date:  2016-04-06       Impact factor: 3.444

Review 2.  Monoamine oxidases as sources of oxidants in the heart.

Authors:  Nina Kaludercic; Jeanne Mialet-Perez; Nazareno Paolocci; Angelo Parini; Fabio Di Lisa
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

Review 3.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

4.  Assay of MAO Inhibition by Chromatographic Techniques (HPLC/HPLC-MS).

Authors:  Tomás Herraiz
Journal:  Methods Mol Biol       Date:  2023

5.  Bioinformatic Analysis of the Flavin-Dependent Amine Oxidase Superfamily: Adaptations for Substrate Specificity and Catalytic Diversity.

Authors:  Margarita A Tararina; Karen N Allen
Journal:  J Mol Biol       Date:  2020-03-19       Impact factor: 5.469

6.  Activity-based probes for studying the activity of flavin-dependent oxidases and for the protein target profiling of monoamine oxidase inhibitors.

Authors:  Joanna M Krysiak; Johannes Kreuzer; Peter Macheroux; Albin Hermetter; Stephan A Sieber; Rolf Breinbauer
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-11       Impact factor: 15.336

7.  Why p-OMe- and p-Cl-β-Methylphenethylamines Display Distinct Activities upon MAO-B Binding.

Authors:  Angélica Fierro; Dale E Edmondson; Cristian Celis-Barros; Marco Rebolledo-Fuentes; Gerald Zapata-Torres
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

Review 8.  Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.

Authors:  Jed N Lampe
Journal:  Front Pharmacol       Date:  2017-08-08       Impact factor: 5.810

9.  Geomfinder: a multi-feature identifier of similar three-dimensional protein patterns: a ligand-independent approach.

Authors:  Gabriel Núñez-Vivanco; Alejandro Valdés-Jiménez; Felipe Besoaín; Miguel Reyes-Parada
Journal:  J Cheminform       Date:  2016-04-18       Impact factor: 5.514

10.  Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.

Authors:  Sophia Schedin-Weiss; Mitsuhiro Inoue; Lenka Hromadkova; Yasuhiro Teranishi; Natsuko Goto Yamamoto; Birgitta Wiehager; Nenad Bogdanovic; Bengt Winblad; Anna Sandebring-Matton; Susanne Frykman; Lars O Tjernberg
Journal:  Alzheimers Res Ther       Date:  2017-08-01       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.